Odyssey Health extends note maturity to 2026
Odyssey Health, Inc. disclosed that it entered into Amendment No. 12 with LGH Investments, LLC to its existing convertible promissory note.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Odyssey Health, Inc. disclosed that it entered into Amendment No. 12 with LGH Investments, LLC to its existing convertible promissory note. The amendment, effective as of April 30, 2026, extends the note’s maturity date to September 30, 2026. All other terms and conditions of the note remain unchanged.
8-K Event Classification
3 items: 1.01, 2.03, 9.01
3 items
Item 1.01
Entry into a Material Definitive Agreement
Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 2.03
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
New maturity date: September 30, 2026
Amendment effective date: April 30, 2026
Amendment execution date: May 18, 2026
+2 more
5 metrics
New maturity date
September 30, 2026
Maturity date of convertible promissory note after Amendment No. 12
Amendment effective date
April 30, 2026
Effective date of Amendment No. 12 with LGH Investments, LLC
Amendment execution date
May 18, 2026
Date Odyssey Health entered into Amendment No. 12
Trading symbol
ODYY
Common stock trading symbol on OTC market
Par value per share
$0.001
Par value of Odyssey Health common stock
Key Terms
Convertible Promissory Note, Emerging growth company, Inline XBRL, Exhibit 10.1
4 terms
Convertible Promissory Note financial
"Amendment No. 12 to Convertible Promissory Note with LGH Investments, LLC"
A convertible promissory note is a loan a company takes now that can later be turned into shares instead of being repaid in cash. Think of it as lending money with the option to accept ownership in the business down the road; that matters to investors because it affects who gets paid first, how much ownership existing shareholders keep, and the company’s future valuation and cash needs. Terms such as conversion price, interest and maturity determine the financial impact.
Emerging growth company regulatory
"Emerging growth company On May 18, 2026, Odyssey Health, Inc."
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Inline XBRL technical
"Cover Page Interactive Data File (embedded within the Inline XBRL document)"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.
Exhibit 10.1 regulatory
"Exhibit 10.1 | Amendment No. 12 to Convertible Promissory Note"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Odyssey Health, Inc. (ODYY) change in its note with LGH Investments?
Odyssey Health, Inc. extended the maturity date of its convertible promissory note with LGH Investments, LLC to September 30, 2026. The change is documented in Amendment No. 12, while all other terms and conditions of the note remain the same.
When is the new maturity date of Odyssey Health’s convertible promissory note?
The maturity date of Odyssey Health’s convertible promissory note is now September 30, 2026. This revised date was agreed in Amendment No. 12 with LGH Investments, LLC, which became effective as of April 30, 2026.
Did Odyssey Health (ODYY) change any other terms of the LGH Investments note?
No, Odyssey Health did not change other terms of the note. Amendment No. 12 with LGH Investments, LLC only extends the maturity date to September 30, 2026, and explicitly states that all other terms and conditions remain the same.
When was Amendment No. 12 between Odyssey Health and LGH Investments entered into?
Odyssey Health entered into Amendment No. 12 with LGH Investments, LLC on May 18, 2026. The amendment is effective as of April 30, 2026 and extends the maturity date of the existing convertible promissory note to September 30, 2026.
Where can investors find the text of Odyssey Health’s Amendment No. 12?
Investors can review the text of Amendment No. 12 in Exhibit 10.1. The company attached this exhibit to the current report and incorporated it by reference, providing the full form of the amendment to the convertible promissory note.
On which market is Odyssey Health, Inc. (ODYY) common stock traded?
Odyssey Health, Inc.’s common stock, with a par value of $0.001 per share, trades under the symbol ODYY on the OTC market. This registration information is listed alongside the company’s other basic corporate and contact details.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates